Astute Medical Obtains $13,000,000 Series B Funding

  • Feed Type
  • Date
    3/8/2011
  • Company Name
    Astute Medical
  • Mailing Address
    3550 General Atomics Court San Diego, CA 92121
  • Company Description
    Astute Medical’s mission is to identify and validate protein biomarkers of severe acute disease.Our focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Our emphasis is on patients who present to the emergency department with acute symptoms and hospitalized patients who are at risk for an acute event.
  • Website
    http://www.astutemedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    De Novo Ventures
  • Venture Investor
    Johnson & Johnson Development Corporation

By posting a comment, you agree to our terms and conditions.